The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - IST GmbH
Consulting or Advisory Role - Cavion; EMD Serono; Genentech/Roche; Novella Clinical; PTC Therapeutics
Patents, Royalties, Other Intellectual Property - Letters of Patent for Oncolytic Poliovirus for Human Tumors
Reductions in exercise behavior and tumor progression in newly diagnosed glioblastoma (GBM) patients.
 
Katherine B. Peters
Consulting or Advisory Role - Agios; Novocure
Research Funding - Agios; BioMimetix; Eisai; Genentech; Merck; VBL Therapeutics
 
Stevie Threatt
No Relationships to Disclose
 
Patrick Healy
No Relationships to Disclose
 
James Emmett Herndon
No Relationships to Disclose
 
Eric S Lipp
No Relationships to Disclose
 
Sujata Panta
No Relationships to Disclose
 
Dina Randazzo
No Relationships to Disclose
 
Gordana Vlahovic
Honoraria - Genentech/Roche; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; Pfizer
Speakers' Bureau - Genentech/Roche; Pfizer
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech/Roche; Pfizer
 
Henry S. Friedman
Employment - Genentech/Roche
Stock and Other Ownership Interests - Arno Therapeutics; IST GmbH; Tactical Therapeutics
Honoraria - Genentech/Roche
Consulting or Advisory Role - Genentech/Roche
Speakers' Bureau - Genentech/Roche
Patents, Royalties, Other Intellectual Property - Letters of Patent for Oncolytic Poliovirus for Human Tumors
 
Annick Desjardins
No Relationships to Disclose